Esperion Therapeutics logo
Esperion Therapeutics ESPR
$ 2.87 -5.51%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

Esperion Therapeutics Total Inventories 2011-2026 | ESPR

Annual Total Inventories Esperion Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
94.5 M 65.6 M 35.2 M 34.4 M 16.1 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
94.5 M 16.1 M 49.2 M

Quarterly Total Inventories Esperion Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
109 M 114 M 99.3 M 80.1 M 84.5 M 73.1 M 51.4 M 45.7 M 39.4 M 35.2 M 29.5 M - 35.7 M 34.4 M 34 M 23.7 M 20 M 16.1 M 16.1 M 16.1 M 16.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
114 M 16.1 M 48.7 M

Total Inventories of other stocks in the Biotechnology industry

Issuer Total Inventories Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
16.2 M - -24.86 % $ 820 K usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
154 M $ 25.87 -0.79 % $ 1.25 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
11.4 M $ 2.71 1.88 % $ 17 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
495 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Albireo Pharma Albireo Pharma
ALBO
194 K - -0.23 % $ 916 M usaUSA
Biogen Biogen
BIIB
2.46 B $ 164.87 0.27 % $ 24 B usaUSA
Baudax Bio Baudax Bio
BXRX
5 M - 0.59 % $ 63 K usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
6.71 M - -6.81 % $ 3.04 B usaUSA
Cara Therapeutics Cara Therapeutics
CARA
2.82 M - -3.03 % $ 260 M usaUSA